Because the reduced expression of CXCR4 by TPD7 was irrespective of HER2 status in breast cancer, we used two of these cell lines, MDA-MB-435s and MDA-MB-231, to gain insights into the mechanisms of TPD7 on down-regulation of CXCR4 in further studies. The gene discussed is ERBB2; the disease is breast cancer.